Medscape
Medscape Neurology PodcastEpisodes
Episodes of Medscape Neurology Podcast
Mark All
Search Episodes...
Dr Diener reports on a wide range of studies in neurology and critical care medicine published in February and March, 2018.
Cerebral morphometric alterations discriminate between children with and without ADHD against a control group.
Researchers have revised the understanding of microbiota's effect on neurodegeneration and have proposed a new word to describe it: mapranosis.
Changes in ABR wave patterns can predict autism risk in most babies. Oren Miron talks about this research and his hopes for the future.
Sleep disturbances starting in midlife and continuing into older age can result in cognitive impairment.
Cutting the risk for natalizumab-related PML, update on disability outcomes with ibudilast, and daclizumab pulled from the global market.
Dr Isaacson reviews the findings from Karolinska Institutet's FINGER report that shows how lifestyle changes prevent cognitive decline even in genetically susceptible people who have the APOE4 gene.
Progress is being made in the search for a simple test for Alzheimer disease.
Dr Diener on a month in neurology research characterized by failures--but also some gains.
Headache specialist Dr Lawrence C. Newman discusses how his patients experience migraine and what promising therapies are on the horizon.
Dr Richard Isaacson on why this new formulation of an ingredient available in most spice racks may be proving effective.
Curing Alzheimer is a lofty goal, says Dr Isaacson. But we should also focus on prevention.
Despite the abandonment of research by some pharmaceutical companies, Dr Isaacson is very hopeful about the future of Alzheimer disease treatment and prevention.
DEFUSE-3 supports a longer window for endovascular treatment of acute ischemic stroke. Plus, problematic recommendations from new stroke guidelines.
Dr Christoph Diener on the 2017 studies that show how even moderate lifestyle interventions can have a major impact.
New research suggests that gamma-secretase modulators show promise in one-day treating Alzheimer dementia.
Dr Alan Jacobs on a new mouse study and its potential therapeutic implications for movement disorders.
Dr Diener presents his picks for 2017's most important breakthroughs in the field of neurology.
Although chronic opioid therapy is associated with explicit harms, Dr Argoff argues that opioids may be medically appropriate for certain patients. What is happening in your practice?
A book offering clinical assessments of President Trump's mental health has become a best seller. It's also a threat to psychiatry's reputation, says Dr Jeffrey Lieberman.
Representatives of the Hospital for Special Surgery describe their successful three-part approach to helping patients and providers.
Dr Richard Isaacson suggests enrolling patients displaying mild cognitive impairment in a clinical trial as an alternative to off-label drug prescribing.
Changes in the DSM-5 and ICD-11 are meant to improve accuracy and reduce stigma but retain access to care, says Dr Jack Drescher.
Dr Diener reviews five studies that run the gamut of neurology--from anticoagulant reversal, MS, and carotid stenosis, to temporal arteritis and complications of long-term opioid use.
Dr Alan Jacobs reviews a pilot study's intriguing results.
Join Podchaser to...
- Rate podcasts and episodes
- Follow podcasts and creators
- Create podcast and episode lists
- & much more
Unlock more with Podchaser Pro
- Audience Insights
- Contact Information
- Demographics
- Charts
- Sponsor History
- and More!
- Account
- Register
- Log In
- Find Friends
- Resources
- Help Center
- Blog
- API
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More
- © 2024 Podchaser, Inc.
- Privacy Policy
- Terms of Service
- Contact Us